Skip to content

Can a 60 year old get schizophrenia? The reality of very late-onset psychosis

While schizophrenia typically emerges in young adulthood, a significant percentage of cases have a later onset. The question, "Can a 60 year old get schizophrenia?" is crucial for distinguishing age-related changes from serious mental health conditions and ensuring proper care.

Quick Summary

Yes, new psychotic symptoms can begin around or after age 60, though experts often refer to this presentation as "very late-onset schizophrenia-like psychosis" (VLOSLP). This late-life psychosis often differs from its early-onset counterpart.

Key Points

  • Possibility of Onset: Yes, a person can experience the first onset of psychotic symptoms, or Very Late-Onset Schizophrenia-Like Psychosis (VLOSLP), after age 60, though it is not common and differs from typical schizophrenia.

  • VLOSLP vs. Early-Onset: VLOSLP is distinct from early-onset schizophrenia, often featuring more organized persecutory delusions, fewer negative symptoms, and being more prevalent in women.

  • Unique Risk Factors: Late-life risk factors like sensory deficits (hearing/vision loss), social isolation, and underlying neurodegenerative processes (like dementia) play a significant role in VLOSLP.

  • Diagnostic Complexity: A diagnosis requires ruling out other conditions common in older adults, such as delirium, medication side effects, and dementia, through a comprehensive medical and psychiatric evaluation.

  • Tailored Treatment: Management for VLOSLP involves a "start low, go slow" approach to medication due to increased sensitivity, alongside crucial psychosocial interventions like CBT and family support.

  • Potential for Remission: While treatment is often long-term, some older adults with VLOSLP can achieve significant symptom remission and improved quality of life with proper, consistent care.

In This Article

Understanding Schizophrenia vs. Very Late-Onset Psychosis

Although the keyword asks about schizophrenia in a 60-year-old, the medical community typically makes a distinction based on the age of onset. Psychotic symptoms that first appear between 40 and 60 are often termed Late-Onset Schizophrenia (LOS). However, when symptoms first emerge after age 60, the condition is more specifically referred to as Very Late-Onset Schizophrenia-Like Psychosis (VLOSLP). While the symptoms can appear similar, VLOSLP often has distinct characteristics and underlying causes that differentiate it from early-onset schizophrenia (EOS), which usually manifests in the late teens to early 30s. Recognizing these differences is key to accurate diagnosis and effective management in older adults.

Clinical Features and Symptom Differences

The clinical presentation of psychosis in older age can differ significantly from that in younger patients. VLOSLP, for example, is often characterized by a different symptom profile.

  • Positive Symptoms: Delusions and hallucinations are common, but the delusions in VLOSLP tend to be more organized, coherent, and persecutory in nature, involving plausible themes such as being robbed or having a neighbor spying on them. Hallucinations can be multi-sensory, including visual, tactile, and olfactory, not just the auditory hallucinations most common in younger patients.
  • Negative Symptoms: VLOSLP typically presents with fewer and less severe negative symptoms compared to EOS. Negative symptoms, such as diminished emotional expression (flat affect), apathy, and social withdrawal, are often less pronounced in older adults experiencing very late-onset psychosis.
  • Cognitive Symptoms: While older patients with VLOSLP may experience some cognitive impairment, formal thought disorder (disorganized thinking) is relatively rare. The cognitive deficits tend to be less severe than those observed in early-onset cases.
  • Premorbid Functioning: Patients who develop VLOSLP often have a history of better premorbid social and occupational functioning compared to those with early-onset schizophrenia.

Risk Factors Associated with Very Late-Onset Psychosis

The factors that contribute to psychosis in late life differ from those in earlier life. Some notable risk factors include:

  • Female Gender: VLOSLP is significantly more common in women, with some studies reporting a female-to-male ratio as high as 22.5:1. The reasons for this are not fully understood, but some theories suggest a link to estrogen withdrawal after menopause.
  • Sensory Impairments: Hearing or visual impairments are common risk factors for psychosis in older adults. Isolation and altered sensory input caused by these deficits may contribute to delusional and hallucinatory experiences.
  • Social Isolation: Loneliness and social withdrawal are well-documented risk factors for late-life psychosis. A loss of social connection can increase vulnerability to developing paranoid beliefs.
  • Neurodegenerative Processes: After age 60, there is a higher risk that psychotic symptoms are secondary to an underlying neurodegenerative condition, such as dementia with Lewy bodies or Alzheimer's disease.
  • Inflammation: Research suggests that aging-related inflammation, indicated by elevated C-reactive protein (CRP), may increase the risk of developing psychosis in late life.

Diagnostic Challenges: Ruling Out Other Conditions

Diagnosing psychosis in an older adult is a complex process. The initial presentation can easily be mistaken for other conditions common in this age group, necessitating a comprehensive evaluation to rule out organic causes.

  1. Thorough Medical Workup: A full medical history, physical examination, and lab investigations are essential. This is to exclude conditions like urinary tract infections, metabolic disturbances, or medication side effects (such as from steroids or Parkinson's medications) that can cause delirium or psychosis.
  2. Neuroimaging: Brain imaging, such as a CT scan or MRI, is often recommended to identify any underlying structural brain abnormalities or cerebrovascular issues.
  3. Cognitive Assessment: Screening for dementia using tools like the Mini Mental State Examination is critical for differential diagnosis. Psychosis related to dementia often presents with prominent cognitive decline and memory issues, whereas VLOSLP typically does not.
  4. Family and Informant Reports: Input from close family members or caregivers is invaluable for an accurate diagnosis, as the older adult's insight may be limited. They can provide a historical context for symptoms and behaviors.
Clinical Feature Early-Onset Schizophrenia (EOS) Very Late-Onset Psychosis (VLOSLP)
Typical Onset Age Late teens to early 30s After age 60
Gender Predominance Roughly equal (slight male bias) Strong female predominance
Genetic Links More significant family history Weaker familial link to schizophrenia
Symptom Profile Prominent negative symptoms and formal thought disorder are common. Negative symptoms and formal thought disorder are rare.
Delusion Characteristics Often bizarre and disorganized Typically persecutory and well-organized, less bizarre
Hallucination Modalities Predominantly auditory Can be multi-sensory (auditory, visual, tactile, olfactory)
Cognitive Impairment Moderate-to-severe deficits common Less severe cognitive impairment
Causative Factors Neurodevelopmental factors, significant genetic influence Often linked to neurodegenerative processes, sensory loss, and social isolation
Medication Response Requires higher antipsychotic doses Responds to lower doses of antipsychotics

Treatment Approaches in Older Adults

Treatment for VLOSLP is tailored to the individual, taking into account their age, comorbidities, and greater sensitivity to medications. The goal is to manage symptoms, improve quality of life, and address underlying issues.

  • Lower-Dose Antipsychotics: Older adults are more susceptible to side effects, so a "start low, go slow" approach is crucial. Lower dosages of atypical antipsychotics are often the first-line treatment due to a reduced risk of extrapyramidal symptoms and tardive dyskinesia compared to older, typical antipsychotics.
  • Psychosocial Interventions: Therapy and support are cornerstones of treatment. Psychosocial approaches can help manage symptoms and promote a positive lifestyle:
    • Cognitive Behavioral Therapy (CBT): Can be adapted to help older adults address delusional beliefs and manage distressing hallucinations.
    • Social Skills Training: Helps combat isolation and improve communication.
    • Family Education: Involving families in the treatment plan helps them understand the condition and provide a supportive environment.
  • Sensory and Environmental Support: Addressing sensory impairments with hearing aids or eyeglasses can significantly reduce psychotic symptoms. Modifying the living environment can also improve safety and reduce confusion.
  • Addressing Underlying Issues: If a medical condition, like a UTI or medication side effect, is the cause, treating the primary condition can resolve the psychotic symptoms.

Conclusion

While the onset of classic schizophrenia is rare after 40, psychotic symptoms can and do appear for the first time in older adults. This condition, often classified as Very Late-Onset Schizophrenia-Like Psychosis (VLOSLP) when it occurs after 60, has a distinct presentation and risk factors. It is critical for caregivers and clinicians to recognize these symptoms and pursue a thorough medical and psychiatric evaluation to differentiate VLOSLP from other geriatric conditions like dementia or delirium. With a personalized approach to treatment, including lower-dose medication and targeted psychosocial support, seniors with late-onset psychosis can effectively manage their symptoms and maintain a good quality of life. For more information and support resources, visit the National Alliance on Mental Illness (NAMI).

Frequently Asked Questions

Schizophrenia is typically diagnosed in young adulthood. Very Late-Onset Schizophrenia-Like Psychosis (VLOSLP) refers to psychotic symptoms, like delusions and hallucinations, that emerge for the first time after age 60. VLOSLP has a different symptom profile, tends to be more common in women, and has a weaker genetic link to early-onset schizophrenia.

Common symptoms include persecutory delusions (e.g., believing someone is stealing from them), multi-sensory hallucinations (seeing, hearing, or smelling things), and social withdrawal. These patients typically have less formal thought disorder and fewer negative symptoms compared to younger patients.

Yes, symptoms can overlap, and it is a common diagnostic challenge. Unlike dementia, which primarily involves progressive cognitive decline and memory loss, VLOSLP is characterized by specific psychotic symptoms. A careful evaluation by a specialist is necessary to distinguish between the conditions.

Specific risk factors include being female, having sensory impairments like vision or hearing loss, experiencing social isolation, and certain neurodegenerative conditions or medical comorbidities. Stressful life events can also be a trigger.

Yes, treatment is highly individualized. Older adults typically require lower doses of atypical antipsychotic medication due to increased sensitivity and risk of side effects. Psychosocial support, such as Cognitive Behavioral Therapy (CBT) and family education, is also a vital component of a comprehensive treatment plan.

If you notice new delusions, hallucinations, or behavioral changes, it is crucial to seek a thorough medical evaluation promptly. A doctor will need to rule out underlying medical causes like infections, side effects from medication, or neurological conditions before a psychiatric diagnosis is considered.

Not necessarily. While it requires ongoing management, many individuals with VLOSLP can achieve a good level of symptom control and maintain a good quality of life with appropriate treatment and support. Remission is possible in some cases.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.